Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Income Statement 2011–2025
| Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenue | 829.4M | 3.6M | 240.7M | 243.2M | 138.3M | 88.0M | 168.8M | 16.1M | 31.4M | 158,333 | 382,000 | 175,000 | 290,266 | 146,875 | 296,139 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||
| Operating Income | 98.3M | -601.1M | -205.0M | -178.5M | -149.0M | -93.2M | 61.2M | -55.9M | -37.0M | -81.7M | -96.0M | -53.3M | -24.6M | -21.1M | -9.8M |
| EBITDA | 120.5M | -584.2M | -194.3M | -169.8M | -142.4M | -89.0M | 63.9M | -52.9M | -34.0M | -78.5M | -93.6M | -51.9M | -22.8M | -19.3M | -9.6M |
| Net Income | -1.6M | -599.5M | -205.3M | -176.1M | -140.8M | -84.6M | 68.0M | -54.5M | -34.4M | -81.7M | -91.9M | -58.6M | -31.1M | -21.1M | -3.1M |
| Per Share Data | |||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 134M | 120M | 107M | 105M | 104M | 101M | 99M | 84M | 74M | 70M | 60M | 55M | 32M | 14M | 8M |
Arrowhead Pharmaceuticals Inc. Income Statement — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) income statement over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARWR's income statement history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.